“…There is substantial and growing evidence that static magnetic fields (SMF) less than 1 tesla (T) can influence physiological processes in vivo: pain [Takeshige and Sato, 1996;Vallbona et al, 1997;Holcomb et al, 2000;Brown et al, 2002;Hinman, 2002;Weintraub et al, 2003], bone repair and formation [Bruce et al, 1987;Mevissen et al, 1994;Darendeliler et al, 1997;Yan et al, 1998;Xu et al, 2001], inflammation and wound healing [Lud and Demeckiy, 1990;Weinberger et al, 1996;Man et al, 1999;Alfano et al, 2001;Segal et al, 2001;Rogachefsky et al, 2004], anticonvulsant effects [McLean et al, 2003], enhanced chemotherapy [Gray et al, 2000], spatial discrimination learning [Levine and Bluni, 1994], melatonin reduction [Welker et al, 1983;Olcese et al, 1985;Olcese and Reuss, 1986;Stehle et al, 1988], cyclic AMP reduction [Rudolph et al, 1988], central nervous system function [Rosen and Lubowsky, 1987;Veliks et al, 2004], action potential generation [Lohmann et al, 1991;Popescu and Willows, 1999;Wang et al, 2003Wang et al, , 2004, enhanced tumor apoptosis [Tofani et al, 2001[Tofani et al, , 2002, and increased c-fos gene expression [Němec et al, 2001]. Therefore, characterizing the physiological transduction mechanism of SMF on BP in both hypertension and hypotension, remains an important area of research toward the development of better p...…”